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INTRODUCTION
Cataracts are a major ophthalmologic
concern, with an incidence throughout
the population (1,2). Cataracts can result
from eye injury through trauma, expo-
sure to sunlight and a variety of age-
 related physiological manifestations in-
cluding inflammatory diseases, diabetes
and genetic predisposition (3–6). Current
cataract therapies include surgical extra-
capsular lens fiber removal and synthetic
lens implantation that can lead to second-
ary cataract (SC), also known as posterior
capsular opacification in humans. In gen-
eral, SC etiology includes the transdiffer-
entiation of anterior capsule residual lens
epithelial cells into mesenchymal myofi-
broblast cells  (epithelial-mesenchymal
transition [EMT]) that can migrate and
expand into the posterior area of the lens
capsule. The corresponding lens opacity
results from EMT- associated changes in
crystallin proteins, upregulation of cy-
toskeletal proteins such as α smooth
muscle actin (α-SMA) and fibrotic extra-
cellular matrix remodeling (7–9). In the
pursuit of novel prevention and postsur-
gical therapies, numerous studies have
focused on analyzing the etiology of SC
formation, looking at the genetic predis-
position and epigenetics as well as ge-
nomic and proteomic gene expression
patterns (5,10,11). To study the detailed
mechanism of SC, rodent cataract surgery
models were successfully used, with lens
epithelial cells undergoing SC during the
initial days after lens fiber removal
(12–14). Recently, we suggested that
 microRNA (miRNA)-dependent post-
transcriptional regulation of lens
 development–associated genes might
also play a role in lens regeneration (15).
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MicroRNAs are small proportional 22-
 nucleotide-long noncoding RNAs that
regulate mRNA breakdown or transla-
tional interference of tissue- specific genes
expressed during development, prolifera-
tion, differentiation and cell death mecha-
nisms (16,17). RNA interference therapy
was proposed as a therapeutic tool for a
variety of clinical conditions (18–20). A
recent study by Park et al. (21) proposed
that specific targeting of SC-associated
regulatory factors such as nuclear factor-
κB (NF-κB) by RNA interference might
provide a promising tool for postsurgical
prevention of SC- associated EMT. Corre-
spondingly, this study uses a previously
established mouse cataract surgery model
for SC (12), microarray hybridization
technology (22) and lens capsular bag
culture to identify the miRNA expression
pattern after cataract surgery and to de-
termine the regulatory role of selective
 miRNAs, in particular miR-184 and miR-
204, on SC etiology.
MATERIALS AND METHODS
Mouse Cataract Surgery
Cataract surgery was performed ac-
cording to Suetsugu-Maki et al. and
Medvedovic et al. (12,13,22) with modifi-
cations. C57BL/6 mice (8 wks old, female;
The Jackson Laboratory, Bar Harbor, ME,
USA) were anesthetized by intraperi-
toneal injections of ketamine and xylazine
(95 and 14.3 mg/kg, respectively). For
analgesia, buprenorphine (1 mg/kg) was
give subcutaneously. The cornea was in-
cised, and anterior capsulectomy was
performed by removal of the lens core
and fiber cells from the lens capsular
bag. Capsular bags were washed with 1×
phosphate-buffered saline (PBS) contain-
ing Mg2+ and Ca2+ to remove residual
fiber cells. After 1, 2 and 3 wks of
cataract surgery, mice were euthanized
and eyeballs were removed to study SC
formation. The posterior eyeballs were
cut off and lens capsules were separated
from the inside of the eyeball. For the
control, intact lens capsules were col-
lected from intact mouse eyes. The lens
capsules were incubated in RNAlater®
(Ambion, Austin, TX, USA) at 4°C
overnight, followed by storage of lens
capsules at –80°C.
Microarray Analysis
Lens tissue was homogenized in  TRIzol
Reagent (Invitrogen, Carlsbad, CA, USA)
for total RNA isolation according to Trask
et al. (23). Total RNA purity, quantity and
quality were determined using a Nan-
oDrop spectrophotometer ND-1000
(Thermo Scientific, Waltham, MA, USA)
and an Agilent Bioanalyzer 2100 (Agilent
Technologies, Santa Clara, CA, USA). The
miRNA was isolated from the total RNA
preparation using the Flash Page™ gel
system (Ambion). The purified miRNA
was amplified using the NCode™ miRNA
Amplification System (Invitrogen) from
which the sense strand RNA was isolated
using the PureLink™ Micro Kit (Invitro-
gen). The sense strand miRNA was la-
beled with cyanine-3 and used for hy-
bridization on mouse miRNA microarray
8 × 15K slide version 2 containing probes
for 627 mouse and 39 mouse γ herpes
virus miRNAs from the Sanger database v
12.0 (Agilent Technologies). Agilent Fea-
ture Extraction software (24) depicted 55
miRNA probes that were detected on at
least one out of four arrays by determina-
tion of the signal-to-error ratio. Intensity
values for each individual time point were
adjusted by setting negative values to “1.”
Data are based on single values. Hierarchi-
cal clustering of mean centered intensities
was employed using a Euclidean distance
measure to generate a heat map for the 55
detectable probes using the open source
software Cluster/Treeview. The software
was written by Michael Eisen while at
Stanford University.
Capsular Bag Culture
A radial incision was made at the bor-
der of the cornea and the sclera using a
scalpel and scissors followed by lens ex-
trusion using forceps. Lenses were
washed in Dulbecco’s modified Eagle
 medium/F12 (DMEM/F12, 1× antibiotics/
antimycotics; Corning® cellgro®, Mediat-
ech Inc., Manassas, VA, USA), and any
residual tissue on the outer lens capsule
was removed supported by incubation in
0.25% trypsin/ EDTA (Cellgro) for 1–5
min. After submersion in DMEM/F12
supplemented with 10% fetal bovine
serum (FBS) (Sigma-Aldrich, St. Louis,
MO, USA), the posterior capsule was po-
sitioned on a ring support structure at the
base of the dish and the anterior capsule
was opened by making three clockwise
incisions, with incisions not extending the
lens equator by keeping the lens posi-
tioned using forceps. The capsule was
peeled from the lens fiber cell mass using
small scissors, and the posterior capsule
was pinned with the exterior facing the
bottom of a 3-mm culture dish and the
anterior edge forming a cuplike structure
(capsular bag) using six entomological
pins (D1; Watkins and Doncaster, Kent,
UK). Residual lens fibers were  removed
by changing the medium to DMEM/F12
without FBS.
miRNA Target Prediction
Target binding sites for miR-184 and
miR-204 were analyzed according to 
the current TargetScan (Bin3, Runx2,
Meis2 [listed below]) and PicTar (Meis2
[listed below]) prediction programs. Re-
garding Mus musculus (mmu) miRNAs,
TargetScan predicted conserved targets
for mmu-miR-184 (18 conserved targets)
and mmu-miR-204 (322 conserved tar-
gets) were screened to identify potential
SC-associated genes listed by the AmiGO
gene ontology database (http:// amigo.
geneontology.org) under the GO terms
GO:0001837: epithelial to mesenchymal
transition (http://amigo. geneontology.
org/ cgi-bin/amigo/ term_ details?term=
GO:0001837&session_id= 4145amigo
1314025373) and GO:0002088: lens devel-
opment in camera-type eye (http://
amigo. geneontology.org/cgi-bin/ amigo/
term_ details?term=GO: 0002088& session_
id= 4145amigo 1314025373). The identified
genes were further analyzed for
 microarray-identified SC-associated
miRNA binding sites using TargetScan
accessed August 2011.
TargetScan predicted targets for mmu-
miR-184 can be found at: http://www.
targetscan.org/cgi-bin/targetscan/
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vert_50/targetscan.cgi?mirg=mmu-miR-
184. TargetScan predicted targets for
mmu-miR-204 can be found at: http://
www.targetscan.org/cgi-bin/targetscan/
vert_50/targetscan.cgi?species=Mouse&
gid=&mir_c=&mir_sc=miR-204/
211&mir_nc=&mirg=&sortType=cs&incl_
nc=0. TargetScan 3′ untranslated regions
(UTR) for Bin3 can be found at: http://
www.targetscan.org/cgi-bin/targetscan/
vert_50/view_gene.cgi?taxid=10090&gs=
BIN3&showcnc=0&shownc=0. TargetScan
3′UTR for Runx2 can be found at: http://
www.targetscan.org/cgi-bin/ targetscan/
vert_50/view_gene.cgi?taxid=10090&gs=
RUNX2&showcnc=0&shownc=0#miR-
204/211. TargetScan 3′UTR for Meis2 can
be found at: http://www. targetscan. org/
cgi-bin/targetscan/ vert_50/ view_gene.
cgi?taxid= 10090&gs= MEIS2&showcnc=
0&shownc=0. To access PicTar 3′UTR for
Meis2, use: http:// pictar.mdc-berlin. de/
cgi-bin/PicTar_ vertebrate.cgi (search
terms: has-miR-204, gene ID NM_172315).
Transfection of Capsular Bags
Capsular bag cultures were transfected
using lipofectamine. Optimal transfection
efficiency for miRNA constructs was de-
termined before experiments by using the
pMIR-REPORT luciferase system (Am-
bion). In brief, the pMIR-REPORT lu-
ciferase plasmid expressing luciferase
mRNA fused to the antisense sequence for
hsa-mir-148a cloned in the Spe1, and the
HindIII multiple cloning site was trans-
fected alone (L-anti-miR) or cotransfected
with hsa-miR-148a (L-anti-miR plus miR-
148a). Firefly luciferase activity was re-
ported from cell lysates 48 h after transfec-
tion according to the Promega Luciferase
Assay System by detecting counts per
minute (cpm) using a scintillation counter
as previously published (15) (Figure 2).
Cell lysates from nontransfected cells were
used to measure background cpm (con-
trol). Samples were done in triplicate, and
each sample included the average of
20 cpm measurements. Data were ana-
lyzed by unpaired Student t test, and P <
0.05 was used as a criterion for signifi-
cance. Transfection efficiency of cy3-
 labeled anti-miR control (AM17011; Am-
bion) at different concentrations (for exam-
ple, 5, 50 and 500 nmol/L) with or with-
out lipofectamine was determined after 24
and 48 h of transfection by counting the
number of cy3-labeled  miRNAs localized
within cell bodies (Figure 2). Human miR-
184 inhibitor (anti-miR-184, AM10207),
anti-miR control (AM17011), precursor
miRNA for miR-204 (pre-miR-204,
PM11116) and pre-miR control (AM17120),
respectively, were mixed under optimized
transfection conditions at a concentration
of 50 μmol/L with 125 μL serum-free
DMEM/F12 for 15 min and combined
with the lipofectamine mixture under
short vortexing and incubation for another
15–30 min. Proportional three to four cap-
sular bag explants per 3-mm Petri dish
were supplemented with serum-free
DMEM/F12 and transfected with the cor-
responding mixture.
Migration and Cell Expansion
Imaging was performed using a TS100
microscope (Nikon, Tokyo, Japan) under
a phase-contrast setting with a charged-
coupled device (CCD) camera (CoolSNAP
cf2; Photometrics, Tucson, AZ, USA) and
imaging software (Metamorph; Molecu-
lar Devices, Eugene, OR, USA). Percent
cell confluence after capsular miRNA
transfection was quantified from two dif-
ferent donor eyes after 24 and 48 h. The
data were derived by dividing each cap-
sular bag into four quadrants followed
by measuring the average area of cells
that migrated to the denuded area. Data
were analyzed by two-way analysis of
variance (ANOVA) by entering the stan-
dard deviation of two donor eyes with
four measurements each (representing
four quadrants). P < 0.05 was used as a
criterion for significance.
Immunohistochemistry
Imaging was performed using a TS100
microscope (Nikon, Tokyo, Japan) under
a fluorescence setting with a CCD camera
(CoolSnapcf2) and imaging software
(Metamorph). After the different transfec-
tion time periods, capsular bags were
washed twice with PBS, followed by fixa-
tion in 2% paraformaldehyde in PBS,
0.1% Triton X-100 for 30 min and staining
with primary mouse monoclonal anti-
body α-SMA 1:250 (Sigma-Aldrich). Inte-
grated optical density of α-SMA expres-
sion after capsular bag transfection with
miRNA constructs was quantified from
two donor eyes (anti-miRNA constructs)
and three donor eyes (pre- miRNA con-
structs) after 24, 48 and 72 h, respectively.
The data were derived by dividing each
capsular bag into four quadrants fol-
lowed by measuring the integrated opti-
cal density of same-size panes in two dif-
ferent capsular locations (for example, the
capsular edge and migration border).
Data of anti-miRNA constructs were ana-
lyzed by two-way ANOVA by entering
the standard deviation of two donor eyes
with four measurements each (represent-
ing four quadrants). Data for pre-miRNA
constructs were analyzed by unpaired
Student t test and two-way ANOVA by
entering the standard error from three
donor eyes with four measurements each
(representing four quadrants). P < 0.05
was used as a criterion for significance.
Protein Extraction
After lens extrusion, capsular bag cul-
ture was established by opening the pos-
terior part of the lens capsule and pinning
the anterior capsule with cells facing the
interior of the capsular bag to preserve
the maximum amount of lens epithelial
cells for miRNA transfection. A total of
four capsular bags were used per protein
sample. To preserve all the cells contained
in a sample, the growth medium contain-
ing supernatant was transferred to an Ep-
pendorf tube. Capsular bag attached ep-
ithelial cells were detached by rigorous
flushing with 750 μL PBS, followed by
transfer of cells to the  supernatant-
containing tube. Proteins were extracted
according to the NE-PER Nuclear and Cy-
toplasmic Extraction Kit (Pierce Biotech-
nology, Rockford, IL, USA). In brief, after
centrifugation at 2,000g and removal of
the supernatant, cells were taken up in 
25 μL Cytoplasmic Extraction Reagent I
(CER I), vortexed and incubated on ice for
10 min. After addition of CER II, samples
were vortexed, incubated on ice for 1 min,
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vortexed and centrifuged at 13,000g for 5
min. The cytoplasmic supernatant was
separated from the nuclear pellet. The nu-
clear pellet was dissolved in 15 μL Nu-
clear Extraction Reagent (NER), vortexed
for 10 min and centrifuged at 13,000g for
5 min. The supernatant containing the nu-
clear fraction was pooled with the cytoso-
lic fraction to obtain total cellular protein
extracts.
Sodium Dodecyl Sulfate–
Polyacrylamide Gel Electrophoresis
(SDS-PAGE) and Western Blotting
The complete protein samples derived
from four lenses each were separated 
on 10% sodium dodecyl sulfate–
 polyacrylamide gels and transferred to
poly vinylidene fluoride (PVDF) mem-
branes. PVDF membranes were incu-
bated with the primary polyclonal anti-
bodies for bridging integrator 3 (BIN3)
(ProteinTech Group, Chicago, IL, USA),
Meis homeobox 2 (MEIS2) (Abcam,
Cambridge, MA, USA), runt-related
transcription factor 2 (RUNX2), β-actin
and  glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) (loading control)
(Santa Cruz Biotechnology, Santa Cruz,
CA, USA). Staining with primary anti-
bodies was followed by fluorescein-
linked secondary antibody at 1:600 
dilution and tertiary antibody anti-
 fluorescein AP conjugate 1:1,000 accord-
ing to the enhanced chemifluorescence
Western Blotting Kit (Amersham, Piscat-
away, NY, USA), and membranes were
scanned with a Biospectrum 500 Imag-
ing System with an LM26 and BioChemi
500 Camera f/1.2 and Vision Works LS
software. Antibody staining intensities
were measured using ImageGauge 4.1
(Fuji Photo Film). Three samples per
group with four lenses per sample were
analyzed. Intensities of primary anti-
body staining were normalized to the 
β-actin or GAPDH loading controls
through division. For comparison of
controls versus miRNA treatments, a
two-tailed unpaired Student t test was
used. P < 0.05 was used as a criterion for
significance. 
All animal studies were approved by
the University of Dayton Laboratory Ani-
mal Institutional Review Board.
All supplementary materials are available
online at www.molmed.org.
RESULTS
Cataract Surgery for miRNA
Expression Profiling
Previously, we demonstrated that SC
can be modeled in mice by surgical re-
moval of lens fibers from the capsular
bag (12). The resulting lens regeneration
after extra-capsular lens fiber removal
consists of two critical phases. The initial
phase is during the first week of regener-
ation and is marked by upregulation of
EMT-specific extracellular matrix compo-
nents, cytoskeletal proteins such as
α-SMA and downregulation of crys-
tallins. The second phase begins at wks 2
and 3 and is marked by an upregulation
of lens structural proteins and lens differ-
entiation (12,13). For the present study, 
8-wk-old C57BL/6 mice underwent
cataract surgery by capsulectomy, as 
previously described (12,13). Following 1,
2 and 3 wks after surgery, RNA was iso-
lated from regenerating lenses to deter-
mine the miRNA expression profiles dur-
ing these different time points.
Cataract Surgery Induces 
SC-Dependent Expression of miRNAs
The broad-spectrum miRNA expression
profile was examined by hybridizing
miRNA probes to a microarray containing
probes for 627 mouse miRNAs from the
Sanger database v. 12.0. Microarray analy-
sis revealed SC-associated changes in ex-
pression pattern of 55 regulatory miRNAs
after mouse cataract surgery (Figure 1). 
A variety of lens development and
 regeneration-specific miRNAs (miR-31,
miR-125b and a variety of the let-7/98
cluster, for example, let-7a, -7b, -7c, -7d, -7e
and -7f) were upregulated after 1 wk of
cataract surgery and declined to baseline
levels over the 3-wk regeneration period
(15,25–29). Regarding other lens-specific
miRNAs (25), miR-184 demonstrated an
upregulation after cataract surgery,
whereas the miR-204/211 cluster demon-
strated a downregulation after cataract
surgery that  continued declining over the
3-wk regeneration period. Further, several
miRNAs such as miR-23a and miR-15b,
that are known to play a role in regenerat-
Figure 1. MicroRNA expression profile after
cataract surgery. Dendrogram based on
clustered miRNA intensity values to dem-
onstrate the subtle differences of miRNA
expression after different time points of
cataract surgery. The intensities are mean
centered, with red indicating values
higher than the average of all four groups
and green indicating lower values.
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ing retinal pigment epithelium, demon-
strated a SC-associated upregulation (30).
Similarly, SC-induced upregulation in
common mediators of eye and neural crest
development (for example, miR-23b and
miR-130a) were identified (31). We also
observed an upregulation of the prolifera-
tion inductive miR-22 after cataract sur-
gery most likely corresponding to the SC-
associated induction of lens epithelial (LE)
cell migration and expansion (32). Regard-
ing the detection of EMT-specific miRNAs,
miR-21, miR-24 and miR-30d expression
was upregulated, whereas miR-30c was
downregulated in accordance with their
role in induction of  fibrotic proliferation
and apoptosis (33–43).
Capsular Bag Culture Using 
Anti-miR-184 and Pre-miR-204
The effect of miRNAs on SC etiology
was studied in a capsular bag culture
model that allows efficient manipulation
of selective miRNA expression with faster
outcomes compared with an animal sur-
gery model and has been previously used
by our group and others (13,44). SC char-
acteristics can be observed within the
first 3 d of capsular bag culture. When
looking at miRNAs that demonstrate
abundant expression in lens with a po-
tential regulatory role in SC, miR-184 and
miR-204 represent promising candidates
(25). For instance, both of these miRNAs
exhibit differential expression patterns
during lens differentiation, regeneration
and cataract etiology (25,27,45,46). In ad-
dition, these two miRNAs were previ-
ously identified to possess binding sites
to the 3′UTRs of potential SC target
mRNAs; for example, miR-184 targets the
cataract-associated GTPase binding pro-
tein bridging integrator 3 [Bin3], and
miR-204 targets the  homeobox transcrip-
tion factor Meis2 and canonical Wnt sig-
naling associated transcription factor
Runx2, respectively (29,47–49). In accor-
dance with the SC observed opposing ex-
pression pattern of miR-204/211 versus
miR-184 and our previous observations
that demonstrated differential expression
of miR-184 and miR-204 during iris cell
dedifferentiation and lens regeneration in
the adult newt (27), both of these miRNAs
were selected for further investigation. To
inhibit potential miR-184–dependent ef-
fects on SC formation that might result
from the observed upregulation of miR-
184 after cataract surgery, the miRNA in-
hibitor anti-miR-184 and the correspon-
ding anti-miR control were chosen.
Equivalent to the observed downregula-
tion of miR-204/211 cluster after cataract
surgery and with regard to the close 
sequence homology between miR-204
and miR-211, we simulated an overex-
pression of the miR204/ 211 cluster by
transfection of pre-miR-204 precursor
miRNA and the corresponding pre-miR
control. Before miRNA transfection of
capsular bag cultures, transfection effi-
ciency was confirmed by microscopy and
luciferase assay (see Figure 2 for detailed
 information).
Attenuation of SC-Associated Cell
Migration and Expansion by 
Anti-miR-184
Within a 3-d time period, all capsular
bag cultures demonstrated SC character-
istic migration and expansion of anterior
LE cell from the capsular edge into the
middle of the posterior capsular bag
area. Anti-miR control transfected cul-
tures demonstrated a 22.73% ± 12.74%
confluence of capsular bags at d 1 and a
96.41% ± 5.06% confluence at d 2 (Fig-
ure 3), resulting in complete confluence
Figure 2. Determination of miRNA transfection efficiency. (A) Determination of 48-h trans-
fection efficiency by confocal microscopy. (a, b, c) Nontransfected control. (d, e, f) Cells
transfected with cy3-labeled anti-miR control. (b, e) Cell bodies were labeled with TOTO-
3 (blue staining). (c, f) Phase-contrast overlay with red and blue panels for detection of
colocalization. The best transfection efficiency of proportional 85% was achieved at a
concentration of 500 nmol/L for 48 h, visible as red staining within TOTO-3–stained cell
bodies. (B) Determination of transfection efficiency by pMIR-REPORT™ luciferase system
(Ambion). Graph demonstrates measured luciferase activity in cpm after 48 h transfec-
tion in nontransfected (control) or MIR-REPORT™ luciferase plasmid expressing luciferase
mRNA fused to the antisense sequence for hsa-mir-148a (L-anti-miR), or cotransfection of
L-anti-miR with hsa-miR-148a (L-anti-miR plus miR-148a). Samples were done in triplicate,
and each sample included the average of 20 cpm measurements. Data were analyzed
by unpaired Student t test, and P < 0.05 was used as a criterion for significance. Error bars
represent standard errors. Firefly luciferase activity was successfully inhibited within the
cotransfected sample of L-anti-miR plus miR-148a (P < 0.05).
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at d 3 (data not shown). In contrast, anti-
miR-184 attenuated migration and ex-
pansion of LE cells significantly (P <
0.005, two-way ANOVA) to 6.49% ±
3.23% confluence of capsular bags at d 1
and 54.36% ± 0.05% confluence at d 2.
Attenuation of SC-Associated Cell
Migration and Expansion by 
Pre-miR-204
Transfection with pre-miR control
demonstrated a SC characteristic appear-
ance of LE cell migration and expansion
to the middle of capsular bags with
23.07% ± 0.34% cell confluence at 
d 1 and 94.66% ± 2.74% confluence at d 2
(see Figure 3), resulting in complete con-
fluence at d 3 (data not shown). Transfec-
tion with pre-miR-204 was comparable to
observations with anti-miR-184, includ-
ing a significant attenuation of LE cell
migration and expansion (P < 0.0001,
two-way ANOVA) to 5.66% ± 1.32% con-
fluence of capsular bags at d 1 and
49.74% ± 0.72% confluence at d 2.
Attenuation of SC-Associated α-SMA
Expression by Anti-miR-184
After 3 d, transfection of capsular bags
with anti-miR-184, or anti-miR control
expression of α-SMA, was analyzed by
immunohistochemistry (Figure 4). In
general, α-SMA expression was mainly
localized at capsular edges and migra-
tion borders and demonstrated an in-
creasing α-SMA integrated optical den-
sity (IOD) over the 3-d time period in the
presence of both anti-miR-184 and anti-
miR control (compare Figure 4 and Fig-
ure 5A). In comparison to the control,
anti-miR-184 demonstrated an attenua-
tion of α-SMA expression at the capsular
edge over the 3-d time period with an
IOD of 5.79 ± 0.01 at d 1 (versus 9.71 ±
2.93, anti-miR control) and 18.55 ± 4.79 at
d 3 (versus 25.16 ± 1.96, anti-miR control)
(P < 0.05, two-way ANOVA) (Figure 5A).
In addition, an attenuation of α-SMA ex-
pression could be observed at the migra-
tion border in the presence of anti-miR-
184 with an IOD of 1.67 ± 0.29 at d 1
(versus 1.99 ± 0.18, anti- miR control) and
6.54 ± 1.04 at d 3 (versus 9.56 ± 0.36, anti-
Figure 3. Attenuation of cell migration and expansion by anti-miR-184 and pre-miR-204. (A)
Cell migration and expansion of LE cells within capsular bag cultures monitored by phase-
contrast microscopy after 0–2 d treatment with anti-miR-184 compared with anti-miR con-
trol and pre-miR-204 compared with pre-miR control. (B) Graphs demonstrate percent cell
confluence determined from d 1 and d 2 in (A) by measuring the average area of cells
that migrated to the denuded area of the capsular bag. The data were derived by divid-
ing each capsular bag into four quadrants followed by measuring the average area of
cells that migrated to the denuded area. Data were analyzed by two-way ANOVA by en-
tering the standard deviation from two donor eyes with four measurements each (repre-
senting four quadrants). Error bars represent standard deviations. P < 0.05 was used as a
criterion for significance.
Figure 4. Reduction of α-SMA expression after anti-miR-184 and pre-miR-204 treatment. (A)
α-SMA expression within capsular bag cultures detected by immunohistochemistry after
1–3 d treatment with anti-miR-184 compared with anti-miR control and pre-miR-204 com-
pared with pre-miR control. (B) Example image demonstrating areas for determination of
IOD in Figure 5 at the capsular edge (yellow squares) and migration border (blue squares).
5 3 4 |  H O F F M A N N  E T  A L .  |  M O L  M E D  1 8 : 5 2 8 - 5 3 8 ,  2 0 1 2
M I R - 1 8 4  A N D  M I R - 2 0 4  I N  S E C O N D A R Y  C A T A R A C T
miR control) (P < 0.005, two-way
ANOVA).
Attenuation of SC-Associated α-SMA
Expression by Pre-miR-204
Similarly, 3-d transfection of capsular
bags with either pre-miR-204 or pre-miR
control demonstrated an  increasing 
α-SMA expression at the capsular edges
and migration borders (compare Figure 4
and Figure 5B). In com parison to the con-
trol, pre-miR-204 demonstrated an attenu-
ation of α-SMA expression over the 3-d
time period at the capsular edge with an
IOD of 3.52 ± 0.44 at d 1 (versus 5.8 ± 1.24,
pre-miR control) and 10.2 ± 0.66 at d 3
(versus 9.3 ± 0.38, pre-miR control) (P <
0.05, two-way ANOVA) (Figure 5B). Be-
cause capsular bags transfected with pre-
miR-204 had reached complete confluence
at d 3, the two-way ANOVA did not yield
any conclusive results regarding temporal
changes of α-SMA IOD over the 3-d time
period. Thus, a significant attenuation of
α-SMA expression could be observed at
the migration border after 2 d transfection
with pre-miR-204 with an IOD of 1.23 ±
0.07 versus 2.65 ± 0.5 (pre-miR control) 
(P < 0.05, Student t test).
Regulation of SC-Associated Target
Expression by Anti-miR-184
One of the predicted miR-184 targets
includes the mRNA for GTPase Bin3. The
selective knockout of Bin3 was found to
promote cataract formation in Bin3
knockout mice (29,50). Correspondingly,
we hypothesized that the presence of
anti-miR-184 might limit a potential miR-
184–dependent downregulation of BIN3
expression during SC. Unexpectedly,
Western blotting analysis demonstrated
no changes in BIN3 protein expression
after 1, 3 and 18 h capsular bag transfec-
tion with anti-miR-184 (data not shown).
Regulation of SC-Associated Target
Expression by Pre-miR-204
One of the predicted mRNA targets
regulated by miR-204 includes the tran-
scription factor MEIS2 (49,51–53). Previ-
ously, miR-204 downregulation and, cor-
respondingly, MEIS2 upregulation was
suggested to cause abnormal lens devel-
opment in the Medaka fish (47). Accord-
ingly, when testing upregulation of miR-
204 by pre-miR-204, we expected a
downregulation of MEIS2 expression.
Western blotting demonstrated a 15%
downregulation of MEIS2 after 3-h trans-
fection of capsular bags with pre-miR-
204 (P < 0.05) (Figure 6A). Interestingly,
MEIS2 protein expression demonstrated
a proportional 7% downregulation after
a 3-h transfection of capsular bags with
anti-miR-184 (P = 0.055), suggesting exis-
tence of a counterregulatory pathway be-
tween the two miRNAs miR-204 and
miR-184 (Figure 6B). No changes of
MEIS2 protein expression could be found
at the earlier 1-h or later 18-h time point
(data not shown).
Besides Meis2, miR-204 was predicted
to regulate other EMT-associated target
mRNAs such as Smad4 and cell cycle reg-
ulators Cdc7, Cdc25b, E2f3 and Runx2
(48,54,55). According to our previous
study that demonstrated an attenuation
of SC-associated Runx2 mRNA expres-
sion in the presence of complement re-
ceptor C5 antagonist after 1 wk of
cataract surgery, Runx2 was chosen as an
additional target for pre-miR-204 treat-
ment (13). In contrast to an expected at-
tenuation of RUNX2, no changes in
RUNX2 protein levels could be detected
in the presence of miR-204 at the differ-
ent time points of 1, 3 and 18 h of capsu-
lar bag culture (data not shown).
Bioinformatic Analysis of MiR-184 and
MiR-204 Target 3′UTR Reveals Multiple
Binding Sites of Other Competitive
miRNAs
To explain these results, we performed
a detailed bioinformatic analysis of all po-
tential SC-associated mRNAs that are tar-
geted by miR-184 or miR-204. We find
that several of these target mRNAs con-
tain 3′UTR binding sites for miRNAs,
with opposing expression patterns during
Figure 5. Reduction of α-SMA expression after anti-miR-184 and pre-miR-204 treatment.
Graph representing data analysis of α-SMA IOD derived from immunohistochemistry in
Figure 4. α-SMA expression within capsular bag cultures detected by immunohistochem-
istry after 1–3 d treatment with anti-miR-184 compared with anti-miR control (A) and pre-
miR-204 compared with pre-miR control (B). Data of anti-miRNA constructs were analyzed
by two-way ANOVA by entering the standard deviation from two donor eyes with four
measurements each (representing four quadrants). Error bars represent standard devia-
tions. Data for pre-miRNA constructs were analyzed by unpaired Student t test and two-
way ANOVA, by entering the standard error from three donor eyes with four measure-
ments each (representing four quadrants). Error bars represent standard errors. P < 0.05
was used as a criterion for significance.
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SC, which alludes to the existence of a
complex network (Figure 7). For example,
Bin3 mRNA demonstrates 3′UTR binding
sites for miR-184 but also for miRNAs of
the Let-7/98 cluster, which are also upreg-
ulated during SC (Figure 7A). Thus, the
Let7 miRNA members might render a po-
tential anti-miR-184 targeting of Bin3 inef-
fective. Likewise, mRNAs for Meis2 and
Runx2 contain many other competitive
miRNAs binding sites in their 3′UTR be-
sides miR-204, suggesting that a potential
downregulation by miR-204 might be ren-
dered ineffective as well (Figure 7B) (see
Discussion for more details on the possi-
ble regulation).
In summary, the results conclude that
miR-184 and miR-204 play a significant
role in the control of SC etiology in mice
and are most likely regulated through a
complex networking with other  miRNAs.
DISCUSSION
Role of miRNAs in Attenuation of SC
Posttranscriptional RNA interference
through miRNA or small interfering
RNA (siRNA) represents a new thera-
peutic tool for treatment of cancer, car-
diovascular disease, fibrosis and antiviral
therapy (56–59). Recently, the group of
Park et al. further confirmed the suitabil-
ity of RNA interference therapy for treat-
ment of SC (21). Accordingly, this study
focused on identifying the SC-associated
miRNA expression pattern after cataract
surgery using microarray technology.
The identified miRNA expression pattern
included 55 miRNAs with different on-
tologies, for example, regulation of cell
growth, differentiation and development,
EMT-dependent fibrosis and lens devel-
opment and cataract. Interestingly, when
looking at changes in lens-specific
 miRNAs, miR-184 demonstrated a SC-
 associated upregulation in comparison to
an observed downregulation of the miR-
204/211 cluster (25). These miRNAs have
also been identified to play a role during
iris cell dedifferentiation and lens regen-
eration in the adult newt, supporting a
potential lens-regenerative function (27).
Having in mind the potential therapeutic
role of miRNAs in prevention of SC,
these two selected miRNAs have pre-
dicted binding sites to the 3′UTR of
cataract-associated target mRNAs, for ex-
ample, the GTPase binding protein Bin3,
the homeobox transcription factor Meis2
and canonical Wnt signaling associated
transcription factor Runx2, respectively
(29,47,48). Correspondingly, miRNA-as-
sociated counterregulation of these EMT-
associated target mRNAs might prevent
formation of SC.
Evidence of SC Attenuation by 
Anti-miR-184 and Pre-miR-204
We found clear evidence that both
anti-miR-184 and pre-miR-204 can atten-
uate SC within the capsular bag model,
supporting the SC regulatory role of
these two miRNAs. Both of these miR-
NAs were able to attenuate anterior LE
cell migration and expansion from the
capsular edge into the middle of the pos-
terior capsular bag area with a propor-
tional 3.5-/4-fold decrease of cell conflu-
ence at d 1 and 1.8-/1.9-fold decrease at
d 2. This result is further supported by
attenuation of α-SMA expression with a
proportional 1.4-fold downregulation of
α-SMA IOD at the capsular edge and a
proportional twofold downregulation of
α-SMA IOD at the migration border over
the 3-d time period in the presence of
anti-miR-184 or pre-miR-204.
Bioinformatic Analysis of miR-184
Target 3′UTR Reveals Multiple Binding
Sites of Other Competitive miRNAs
One explanation for the insufficient
regulation of BIN3 expression by anti-
miR-184 targeting is the existence of
other competitive miRNA binding sites
within the 3′UTR of Bin3 mRNA. For in-
stance, TargetScan (http://targetscan.org)
predictions identify a binding site for
miR-184 at the position 264–270 of the
Bin3 3′UTR, thus also predicting a bind-
ing site for the let-7/98 cluster at posi-
tion 348–354 (compare the Bin3 Web ad-
dress in the Materials and Methods
section and Figure 7A). Because of the
observed upregulation of most let-7/98
cluster members, the intended miR-184
attenuation by anti-miR-184 might not be
sufficient in preventing a potential SC-
 associated downregulation of BIN3.
Figure 6. Attenuation of MEIS2 expression after pre-miR-204 and anti-miR-184 treatment.
Western blot analysis of MEIS2 expression within LE cells after 3 h of pre-miR control or pre-
miR-204 treatment (A) or anti-miR control or anti-miR-184 treatment (B). Blots were stained
with the primary polyclonal antibodies for MEIS2 as well as β-actin or GAPDH (loading
control). Graphs represent Image Gage 4.1 densitometric analysis of MEIS2 expression
ratio in the upper panel. Three samples per group with four lenses per sample were ana-
lyzed. Intensities of MEIS2 were normalized to the β-actin or GAPDH loading controls
through division. For comparison of controls versus miRNA treatments, a two-tailed un-
paired Student t test was used. Error bars represent standard errors. P < 0.05 was used as a
criterion for significance.
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Including Bin3 TargetScan predicted a
total of 18 mmu-miR-184–specific target
mRNAs, suggesting that the observed SC
attenuation might also include miR-184–
dependent regulation and targeting of
other mRNAs (compare to the mmu-
miR-184 Web address in Materials and
Methods).
Bioinformatic Analysis of miR-204
Target 3′UTR Reveals Multiple Binding
Sites of Other Competitive miRNAs
Besides binding of miR-204/211 at po-
sition 3770–3776 within the 3′UTR of
Runx2, TargetScan predictions identify
multiple other miRNA binding sites, in-
cluding the mir23a/b cluster at position
996–1002 and two miR-30c/d clusters at
position 3445–3451 and position 3456–
3462 (compare the Runx2 Web addresses
in Materials and Methods and Figure 7B).
In accordance with the SC- associated up-
regulation of miR-30d and the miR-23a/b
cluster, the pre-miR-204– dependent effect
on Runx2 target mRNA expression might
be rendered ineffective.
Similarly, the PicTar Web interface
(http://pictar.mdc-berlin.de) predicts
multiple other miRNA binding sites for
the Meis2 3′UTR besides miR-204/211,
including SC upregulated miR-23a/b,
miR-27a and the let-7/98 cluster, as well
as miR-181b. In contrast to older
 TargetScan predictions, the current pa-
rameters of TargetScan do not include
any defined target binding site for the
miR-204/ 211 cluster within the Meis2
3′UTR. Thus, current TargetScan predic-
tions for Meis2 match the PicTar predic-
tions regarding binding sites for miR-
23a/b, miR-27a and the let-7/98 cluster,
but also include miR-22, miR-30d and SC
downregulated miR-30c (compare the
Meis2 Web addresses in Materials and
Methods and Figure 7B). Correspond-
ingly, the  potential competition of these
other Meis2-specific miRNAs with miR-
204– dependent regulation of MEIS2 ex-
pression, might account for the limited
15% downregulation of MEIS2 by pre-
miR-204 in our experiment.
Including Meis2 and Runx2 TargetScan
predicted a total of 322 mmu-miR-204–
specific target mRNAs, suggesting that
miR-204 regulation of other mRNAs
might also be relevant for the observed
SC attenuation (compare to the mmu-
miR-204 Web address in Materials and
Methods).
Bioinformatic Analysis of miR-184 and
miR-204 Target Gene Ontology
Database Reveals a Complex miRNA
Network
To support the suggestion that miR-184
might regulate other SC-associated 
target mRNAs besides Bin3, the 18
 TargetScan–predicted miR-184 targets
were screened for a potential match with
genes listed by the AmiGO gene ontology
database (http://amigo.geneontology. org)
under the GO terms GO:0001837: epithelial
to mesenchymal transition and
Figure 7. MicroRNA 184 and 204 competi-
tive RNA network during SC-associated
EMT. Schematic diagram demonstrating
binding patterns of SC-associated miRNAs
to the 3′UTR of potential SC expressed tar-
get mRNAs. Target mRNAs are shown for
mmu-miR-184 (A) and mmu-miR-204 (B)
identified by TargetScan predictions fol-
lowed by screening for potential SC-
 associated genes that play a role during
EMT listed by the AmiGO gene ontology
under the GO terms GO:0001837:epithelial
to mesenchymal transition and GO:0002088:
lens development in camera-type eye. 
MicroRNA 3′UTR binding sites are demon-
strated in circles with numbers depicting
the specific type of microRNA. SC-
 associated microRNA upregulation is indi-
cated by red circles and downregulation
by green circles. SC-associated target
mRNA upregulation is in red and down-
regulation is in green.
Figure 8. Summary diagram of miR-184
and miR-204 competitive RNA network in
control of mouse secondary cataract. The
SC-determined broad-spectrum miRNA
expression profile revealed changes in ex-
pression patterns of major lens differentia-
tion/regeneration- and EMT-associated
 miRNAs (upregulation indicated with red
arrows and downregulation indicated
with green arrows). Accordingly, the
 microRNAs miR-184 and miR-204 were
chosen for further analysis because of
their differential expression patterns during
SC that can also be observed during lens
differentiation, regeneration and cataract
etiology (25,27,34,35). The experimental
manipulation of miRNA expression by the
anti-miR-184–dependent downregulation
of miR-184 and pre-miR-204–dependent
upregulation of miR-204 is suggested to re-
sult in the mechanistic interplay with other
co- or counterregulatory miRNAs for the
modulation of potential SC target mRNAs
and attenuation of SC EMT. Vice versa, the
miRNA- dependent modulation of SC tar-
get mRNAs might include alterations in
transcription factors relevant for expression
of SC EMT attenuating miRNAs.
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GO:0002088:lens development in camera-
type eye. Besides Bin3, two other potential
miR-184 target mRNAs, for example, eye
 development–associated factors Epb41l5
and Zic4, were identified by this method
(60,61) (Figure 7A and Supplementary Fig-
ure 1A). Interestingly, transforming
growth factor (TGF)-β–dependent upregu-
lation of EPB41L5 participates in posttran-
scriptional regulation of cadherin and inte-
grin important for EMT during mouse
gastrulation. Thus, the role of EPB41L5 in
SC-associated EMT in adult mice remains
to be determined (62).
Similarly, the 322 TargetScan predicted
miR-204 targets were screened for a po-
tential match with genes listed by the
AmiGO gene ontology database (http://
amigo.geneontology.org) under the GO
terms GO:0001837 and GO:0002088. Be-
sides Meis2 and Runx2, nine potential SC-
associated miR-204 target mRNAs were
identified. For instance, the miR-204 tar-
gets Meis1, Wnt4, Foxc1,  Hnrnpa2b1,
Tfap2a, Mafg and Sox1 represent important
factors in regulation of eye development
(63–69) (Figure 7B and Supplementary
Figure 1B). In addition, the two identified
miR-204 targets Dlg1 and Tgfbr2 represent
some potential candidates for regulation
of SC-dependent EMT (70–72). For in-
stance, upregulation of TGF-β2 receptors
(TGFBR2) can be found in regenerating
lens epithelial cells after UVB irradiation
(72). In addition, DLG1 downregulation
was associated with EMT in a mouse ocu-
lar tumor model (70).
Interestingly, when looking at expres-
sion of SC-associated miRNAs in correla-
tion with binding to miR-204 target
mRNAs, mRNAs of the major develop-
mental factors, for example, Wnt4, Foxc1
and Hnrnpa2b, are solely regulated by
miR-204/211 with two binding sites of
miR-204/211 within the 3′UTR of Wnt4
(Supplementary Figure 1B). In contrast,
3′UTRs of Tfap2a and Sox11 seem to be
coregulated by miR-204/211 and miR-
92a. In addition, 3′UTRs of Meis2, Runx2,
Tgfbr2, Dlg1, Meis1 and Sox11 share bind-
ing sites for the miR-23a/b cluster, sug-
gesting a miR-204 counterregulatory
function of miR-23a/b. Further common
miRNA binding sites include the let-7/98
cluster in the 3′UTR of Bin3 and Meis2
and the miR-30c/d cluster in the 3′UTR
of Epb41l5 and Zic4 as well as Meis2,
Runx2 and Mafg. These findings further
support existence of a competitive
miRNA network for target mRNAs
 regulated by miR-184 and miR-204.
CONCLUSION
In summary, our study demonstrates
the complex miRNA network interactions
during formation of SC in mice. Although
the tested miRNAs, for example, anti-
miR-184 and pre-miR-204, achieved a par-
tial attenuation of SC-associated EMT,
most likely, the mechanistic interplay of
these miRNAs with potential SC target
mRNAs and other co- or counterregula-
tory miRNAs needs to be considered (see
Figure 8 for further explanation). Such
miRNA networks have previously been
suggested by our group and others, in-
cluding a recent hypothesis that under-
lines the existence of a competitive en-
dogenous RNA (ceRNA) network
(15,73–75). With this in mind, our study
opens new avenues for future studies that
target the competitive miRNA network
for SC therapy and other diseases.
ACKNOWLEDGMENTS
This work was supported by National
Institutes of Health grant EY16707 to
PA Tsonis.
DISCLOSURE
The authors declare that they have no
competing interests as defined by Molecu-
lar Medicine, or other interests that might
be perceived to influence the results and
discussion reported in this paper.
REFERENCES
1. Li Z, Cui H, Zhang L, Liu P, Bai J. (2009) Preva-
lence of and associated factors for corneal blind-
ness in a rural adult population (the southern
Harbin eye study). Curr. Eye Res. 34:646–51.
2. Klein BE, Klein R, Linton KL. (1992) Prevalence
of age-related lens opacities in a population: The
Beaver Dam Eye Study. Ophthalmology. 99:546–52.
3. Blakely EA, et al. (2010) Radiation cataractogene-
sis: epidemiology and biology. Radiat. Res.
173:709–17.
4. Davies MJ, Truscott RJ. (2001) Photo-oxidation of
proteins and its role in cataractogenesis. J. Pho-
tochem. Photobiol. B. 63:114–25.
5. Shiels A, Bennett TM, Hejtmancik JF. (2010) Cat-
Map: putting cataract on the map. Mol Vis
16:2007–15.
6. Rao GN, Khanna R, Payal A. (2011) The global
burden of cataract. Curr. Opin. Ophthalmol.
22:4–9.
7. Saika S, et al. (2009) TGF beta in fibroproliferative
diseases in the eye. Front. Biosci. (Schol. Ed.).
1:376–90.
8. Clark JI, Matsushima H, David LL, Clark JM.
(1999) Lens cytoskeleton and transparency: a
model. Eye (Lond.). 13:417–24.
9. Ihanamaki T, Pelliniemi LJ, Vuorio E. (2004) Col-
lagens and collagen-related matrix components
in the human and mouse eye. Prog. Retin. Eye
Res. 23:403–34.
10. Saika S, et al. (2008) Fibrotic disorders in the eye:
targets of gene therapy. Prog. Retin. Eye Res.
27:177–96.
11. Cvekl A, Mitton KP. (2010) Epigenetic regulatory
mechanisms in vertebrate eye development and
disease. Heredity. 105:135–51.
12. Call MK, Grogg MW, Del Rio-Tsonis K, Tsonis
PA. (2004) Lens regeneration in mice: implica-
tions in cataracts. Exp. Eye Res. 78:297–9.
13. Suetsugu-Maki R, et al. (2011) A complement re-
ceptor C5a antagonist regulates epithelial to mes-
enchymal transition and crystallin expression after
lens cataract surgery in mice. Mol. Vis. 17:949–64.
14. Lois N, et al. (2005) Effect of TGF-beta2 and anti-
TGF-beta2 antibody in a new in vivo rodent
model of posterior capsule opacification. Invest.
Ophthalmol. Vis. Sci. 46:4260–6.
15. Nakamura K, et al. (2010) miRNAs in newt lens
regeneration: specific control of proliferation and
evidence for miRNA networking. PLoS One.
5:e12058.
16. Ambros V. (2004) The functions of animal mi-
croRNAs. Nature. 431:350–5.
17. Bartel DP. (2004) MicroRNAs: genomics, biogene-
sis, mechanism, and function. Cell. 116:281–97.
18. Kaucsar T, Racz Z, Hamar P. (2010) Post-
 transcriptional gene-expression regulation by
micro RNA (miRNA) network in renal disease.
Adv. Drug Deliv. Rev. 62:1390–401.
19. Hinkel R, Trenkwalder T, Kupatt C. (2011) Gene
therapy for ischemic heart disease. Expert Opin.
Biol. Ther. 11:723–37.
20. Oba S, et al. (2010) miR-200b precursor can ame-
liorate renal tubulointerstitial fibrosis. PLoS One.
5:e13614.
21. Park HY, et al. (2010) Effects of nuclear factor-
kappaB small interfering RNA on posterior cap-
sule opacification. Invest. Ophthalmol. Vis. Sci.
51:4707–15.
22. Medvedovic M, Tomlinson CR, Call MK, Grogg
M, Tsonis PA. (2006) Gene expression and dis-
covery during lens regeneration in mouse: regu-
lation of epithelial to mesenchymal transition
and lens differentiation. Mol. Vis. 12:422–40.
23. Trask HW, et al. (2009) Microarray analysis of cy-
toplasmic versus whole cell RNA reveals a con-
siderable number of missed and false positive
mRNAs. RNA. 15:1917–28.
24. Zahurak M, et al. (2007) Pre-processing Agilent
microarray data. BMC Bioinformatics. 8:142.
25. Ryan DG, Oliveira-Fernandes M, Lavker RM.
(2006) MicroRNAs of the mammalian eye display
distinct and overlapping tissue specificity. Mol.
Vis. 12:1175–84.
26. Shen J, et al. (2008) MicroRNAs regulate ocular
neovascularization. Mol. Ther. 16:1208–16.
27. Tsonis PA, et al. (2007) MicroRNAs and regenera-
tion: Let-7 members as potential regulators of
dedifferentiation in lens and inner ear hair cell
regeneration of the adult newt. Biochem. Biophys.
Res. Commun. 362:940–5.
28. Frederikse PH, Donnelly R, Partyka LM. (2006)
miRNA and Dicer in the mammalian lens: ex-
pression of brain-specific miRNAs in the lens.
Histochem. Cell. Biol. 126:1–8.
29. Tian L, Huang K, DuHadaway JB, Prendergast
GC, Stambolian D. (2010) Genomic profiling of
miRNAs in two human lens cell lines. Curr. Eye
Res. 35:812–8.
30. Kutty RK, et al. (2010) MicroRNA expression in
human retinal pigment epithelial (ARPE-19)
cells: increased expression of microRNA-9 by
N-(4-hydroxyphenyl)retinamide. Mol. Vis.
16:1475–86.
31. Gessert S, Bugner V, Tecza A, Pinker M, Kuhl M.
(2010) FMR1/FXR1 and the miRNA pathway are
required for eye and neural crest development.
Dev. Biol. 341:222–35.
32. Ting Y, Medina DJ, Strair RK, Schaar DG. (2010)
Differentiation-associated miR-22 represses Max
expression and inhibits cell cycle progression.
Biochem. Biophys. Res. Commun. 394:606–11.
33. Wang Q, et al. (2008) MicroRNA miR-24 inhibits
erythropoiesis by targeting activin type I recep-
tor ALK4. Blood. 111:588–95.
34. Sun Q, et al. (2008) Transforming growth factor-
beta-regulated miR-24 promotes skeletal muscle
differentiation. Nucleic Acids Res. 36:2690–9.
35. Chan MC, et al. (2010) Molecular basis for antag-
onism between PDGF and the TGFbeta family of
signalling pathways by control of miR-24 expres-
sion. EMBO J. 29:559–73.
36. Cheng AM, Byrom MW, Shelton J, Ford LP. (2005)
Antisense inhibition of human miRNAs and indi-
cations for an involvement of miRNA in cell
growth and apoptosis. Nucleic Acids Res. 33:1290–7.
37. Hoover LL, Kubalak SW. (2008) Holding their
own: the noncanonical roles of Smad proteins.
Sci. Signal. 1:pe48.
38. Liu G, et al. (2010) miR-21 mediates fibrogenic ac-
tivation of pulmonary fibroblasts and lung fibro-
sis. J. Exp. Med. 207:1589–97.
39. Yao Q, et al. (2011) Micro-RNA-21 regulates TGF-
beta-induced myofibroblast differentiation by
targeting PDCD4 in tumor-stroma interaction.
Int. J. Cancer. 128:1783–92.
40. Wang Y, Lee CG. (2009) MicroRNA and cancer:
focus on apoptosis. J. Cell. Mol. Med. 13:12–23.
41. Ozcan S. (2009) MiR-30 family and EMT in
human fetal pancreatic islets. Islets. 1:283–5.
42. Duisters RF, et al. (2009) miR-133 and miR-30 reg-
ulate connective tissue growth factor: implica-
tions for a role of microRNAs in myocardial ma-
trix remodeling. Circ. Res. 104:170–8.
43. Joglekar MV, et al. (2009) The miR-30 family mi-
croRNAs confer epithelial phenotype to human
pancreatic cells. Islets. 1:137–47.
44. Wormstone IM, Wang L, Liu CS. (2009) Posterior
capsule opacification. Exp. Eye Res. 88:257–69.
45. Conte I, et al. miR-204 is required for lens and
retinal development via Meis2 targeting. Proc.
Natl. Acad. Sci. U. S. A. 107:15491–6.
46. Hughes AE, et al. (2011) Mutation altering the
miR-184 seed region causes familial keratoconus
with cataract. Am. J. Hum. Genet. 89:628–33.
47. Conte I, et al. (2010) miR-204 is required for lens
and retinal development via Meis2 targeting.
Proc. Natl. Acad. Sci. U. S. A. 107:15491–6.
48. Huang J, Zhao L, Xing L, Chen D. (2010) Micro -
RNA-204 regulates Runx2 protein expression and
mesenchymal progenitor cell differentiation.
Stem Cells. 28:357–64.
49. Zhang X, Friedman A, Heaney S, Purcell P, Maas
RL. (2002) Meis homeoproteins directly regulate
Pax6 during vertebrate lens morphogenesis.
Genes. Dev. 16:2097–107.
50. Ramalingam A, et al. (2008) Bin3 deletion causes
cataracts and increased susceptibility to lym-
phoma during aging. Cancer Res. 68:1683–90.
51. Bumsted-O’Brien KM, Hendrickson A,
Haverkamp S, Ashery-Padan R, Schulte D. (2007)
Expression of the homeodomain transcription
factor Meis2 in the embryonic and postnatal
retina. J. Comp. Neurol. 505:58–72.
52. Heine P, Dohle E, Bumsted-O’Brien K, Engel -
kamp D, Schulte D. (2008) Evidence for an evolu-
tionary conserved role of homothorax/ Meis1/2
during vertebrate retina development. Develop-
ment. 135:805–11.
53. Karali M, et al. (2010) miRNeye: a microRNA ex-
pression atlas of the mouse eye. BMC Genomics.
11:715.
54. Kuokkanen S, et al. (2010) Genomic profiling of
microRNAs and messenger RNAs reveals hor-
monal regulation in microRNA expression in
human endometrium. Biol. Reprod. 82:791–801.
55. Arora A, et al. (2010) Prediction of microRNAs af-
fecting mRNA expression during retinal develop-
ment. BMC Dev. Biol. 10:1.
56. Hemida MG, Ye X, Thair S, Yang D. (2010) Ex-
ploiting the therapeutic potential of microRNAs
in viral diseases: expectations and limitations.
Mol. Diagn. Ther. 14:271–82.
57. Jamaluddin MS, et al. (2011) miRNAs: roles and
clinical applications in vascular disease. Expert
Rev. Mol. Diagn. 11:79–89.
58. Gandellini P, Profumo V, Folini M, Zaffaroni N.
(2011) MicroRNAs as new therapeutic targets
and tools in cancer. Expert Opin. Ther. Targets.
15:265–79.
59. Jiang X, Tsitsiou E, Herrick SE, Lindsay MA.
(2010) MicroRNAs and the regulation of fibrosis.
FEBS J. 277:2015–21.
60. Christensen AK, Jensen AM. (2008) Tissue-
 specific requirements for specific domains in the
FERM protein Moe/Epb4.1l5 during early zebra -
fish development. BMC Dev. Biol. 8:3.
61. Horng S, et al. (2009) Differential gene expression
in the developing lateral geniculate nucleus and
medial geniculate nucleus reveals novel roles for
Zic4 and Foxp2 in visual and auditory pathway
development. J. Neurosci. 29:13672–83.
62. Hirano M, Hashimoto S, Yonemura S, Sabe H,
Aizawa S. (2008) EPB41L5 functions to post-
 transcriptionally regulate cadherin and integrin
during epithelial-mesenchymal transition. J. Cell.
Biol. 182:1217–30.
63. Hisa T, et al. (2004) Hematopoietic, angiogenic
and eye defects in Meis1 mutant animals. EMBO
J. 23:450–9.
64. Wan X, et al. (2010) Negative feedback regulation
of Wnt4 signaling by EAF1 and EAF2/U19. PLoS
One. 5:e9118.
65. Acharya M, Huang L, Fleisch VC, Allison WT,
Walter MA. (2011) A complex regulatory network
of transcription factors critical for ocular devel-
opment and disease. Hum. Mol. Genet.
20:1610–24.
66. Fang X, et al. Landscape of the SOX2 protein-
 protein interactome. Proteomics. 11:921–934.
67. Al-Dosari MS, et al. (2010) Ocular manifestations
of branchio-oculo-facial syndrome: report of a
novel mutation and review of the literature. Mol.
Vis. 16:813–8.
68. Lecoin L, Sii-Felice K, Pouponnot C, Eychene A,
Felder-Schmittbuhl MP. (2004) Comparison of
maf gene expression patterns during chick em-
bryo development. Gene Expr. Patterns. 4:35–46.
69. Wurm A, Sock E, Fuchshofer R, Wegner M,
Tamm ER. (2008) Anterior segment dysgenesis in
the eyes of mice deficient for the high-mobility-
group transcription factor Sox11. Exp. Eye Res.
86:895–907.
70. Vieira V, et al. (2008) Differential regulation of
Dlg1, Scrib, and Lgl1 expression in a transgenic
mouse model of ocular cancer. Mol. Vis.
14:2390–403.
71. Nguyen MM, et al. (2003) Requirement of PDZ-
containing proteins for cell cycle regulation and
differentiation in the mouse lens epithelium. Mol.
Cell. Biol. 23:8970–81.
72. Osada H, et al. (2011) Ultraviolet B-induced ex-
pression of amphiregulin and growth differentia-
tion factor 15 in human lens epithelial cells. Mol.
Vis. 17:159–69.
73. Tuccoli A, Poliseno L, Rainaldi G. (2006) miRNAs
regulate miRNAs: coordinated transcriptional
and post-transcriptional regulation. Cell Cycle.
5:2473–6.
74. Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi
PP. (2011) A ceRNA hypothesis: the Rosetta Stone
of a hidden RNA language? Cell. 146:353–8.
75. Seitz H. (2009) Redefining microRNA targets.
Curr. Biol. 19:870–3.
M I R - 1 8 4  A N D  M I R - 2 0 4  I N  S E C O N D A R Y  C A T A R A C T
5 3 8 |  H O F F M A N N  E T  A L .  |  M O L  M E D  1 8 : 5 2 8 - 5 3 8 ,  2 0 1 2
